Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 1, Pages e0115895
Publisher
Public Library of Science (PLoS)
Online
2015-01-23
DOI
10.1371/journal.pone.0115895
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma
- (2013) N. Harimoto et al. BRITISH JOURNAL OF SURGERY
- Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies
- (2013) Sami Antoun et al. CANCER
- Accurate diagnosis of sarcopenia in the elderly requires correct measurement of muscle mass
- (2013) Umut Safer et al. CLINICAL NUTRITION
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Body composition and its association with cardiometabolic risk factors in the elderly: A focus on sarcopenic obesity
- (2012) Ji-Youn Chung et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis
- (2012) J Ishioka et al. BRITISH JOURNAL OF CANCER
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
- (2012) Kenneth C.H. Fearon et al. Cell Metabolism
- Hypoxia-inducible factors as key regulators of tumor inflammation
- (2012) Soulafa Mamlouk et al. INTERNATIONAL JOURNAL OF CANCER
- Role of C-reactive protein in urological cancers: A useful biomarker for predicting outcomes
- (2012) Kazutaka Saito et al. INTERNATIONAL JOURNAL OF UROLOGY
- Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987
- (2012) Joaquim Bellmunt et al. JOURNAL OF CLINICAL ONCOLOGY
- Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
- (2011) Michael S. Sabel et al. ANNALS OF SURGICAL ONCOLOGY
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
- (2010) S. Antoun et al. ANNALS OF ONCOLOGY
- Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)
- (2010) S. Lim et al. DIABETES CARE
- Prognostic Factors in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract Experiencing Treatment Failure With Platinum-Containing Regimens
- (2010) Joaquim Bellmunt et al. JOURNAL OF CLINICAL ONCOLOGY
- Ethnic differences in body composition and the associated metabolic profile: A comparative study between Asians and Caucasians
- (2010) S.N. Wulan et al. MATURITAS
- Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
- (2009) B. H.L. Tan et al. CLINICAL CANCER RESEARCH
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More